Immune Cell Gene Features in Ischemic Stroke
Author Information
Author(s): Li Yanbo, Liu Sicheng, Wen Linda, Zhang Linzhu, Lei Xue, Zhang Yaguang, Qiu Lei, He Li, Han Junhong
Primary Institution: West China Hospital, Sichuan University
Hypothesis
The study aims to profile immune cell-related gene features and construct an immunoregulatory ceRNA network in ischemic stroke.
Conclusion
The study identifies distinct immune features between ischemic stroke patients and healthy controls, suggesting potential therapeutic targets.
Supporting Evidence
- Immune cell proportions changed significantly in ischemic stroke patients compared to healthy controls.
- Eleven distinct immune cell-related genes were identified as potential biomarkers.
- A ceRNA network was constructed based on differentially expressed mRNAs, miRNAs, and lncRNAs.
- HECW2 was validated as a key gene in the immune response during ischemic stroke.
- Distinct immune profiles were observed in the peripheral blood of ischemic stroke patients.
Takeaway
This study looks at how certain genes in immune cells change when someone has a stroke, which could help doctors find new ways to treat it.
Methodology
The study used transcriptome datasets, CIBERSORT for immune cell proportion analysis, and machine learning algorithms to identify key genes.
Potential Biases
Pooling datasets may introduce batch effects and technical variations that could confound biological signals.
Limitations
The study's findings may be influenced by demographic differences between IS patients and controls, and the sample size for in-house data was relatively small.
Participant Demographics
The study included 223 participants, comprising 176 ischemic stroke patients and 47 healthy controls.
Statistical Information
P-Value
0.03
Confidence Interval
95% CI, 1.252–5.724
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website